Altered intracellular signaling by imatinib increases the anti‐cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells

Publisher: John Wiley & Sons Inc

E-ISSN: 1349-7006|109|1|121-131

ISSN: 1347-9032

Source: Cancer Science, Vol.109, Iss.1, 2018-01, pp. : 121-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract